Back to overview

A combined chemogenomic and shRNA-screening platform identifies CK2 as a novel target for pro-senescence therapy in PTEN null tumors

Type of publication Peer-reviewed
Publikationsform Original article (peer-reviewed)
Author Madhuri Kalathur, Alberto Toso, Jingjing Chen, Ajinkya Revandkar, Andrea Alimonti,
Project Manipulation of senescence pathways for cancer therapy: from experimental models to clinic
Show all

Original article (peer-reviewed)

Journal Nature Communications
Title of proceedings Nature Communications